Kamli-Salino, Sarah E.J.Brown, Paul A.J.Haschler, Timo N.Liang, LihuanFeliers, DenisWilson, Heather M.Delibegovic, Mirela2023-08-072023-08-072023-04-02Kamli-Salino, S E J, Brown, P A J, Haschler, T N, Liang, L, Feliers, D, Wilson, H M & Delibegovic, M 2023, 'Induction of experimental diabetes and diabetic nephropathy using anomer-equilibrated streptozotocin in male C57Bl/6J mice', Biochemical and Biophysical Research Communications, vol. 650, pp. 109-116. https://doi.org/10.1016/j.bbrc.2023.01.0890006-291XRIS: urn:FC74D877802371EEA3E3B55465035490ORCID: /0000-0002-1407-7274/work/128322416ORCID: /0000-0001-6193-3152/work/160847585ORCID: /0000-0002-5107-5366/work/128239304https://hdl.handle.net/2164/21417Open Access via the Elsevier Agreement This research has been funded by the Medical Research Scotland (PhD-1285-2018), PhD studentship to SEJKS, in partnership with AstraZeneca (Cambridge, United Kingdom).82394035engSDG 3 - Good Health and Well-beingStreptozotocinExperimental diabetesDiabetic nephropathyHyperglycaemiaR MedicineMolecular BiologyBiophysicsBiochemistryCell BiologyScottish Funding CouncilPhD-1285-2018RJournal article10.1016/j.bbrc.2023.01.089http://www.scopus.com/inward/record.url?scp=85147864442&partnerID=8YFLogxK650